Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Colon Cancer, Precancerous Condition, Rectal Cancer

In brief

This randomized phase II trial is studying how well aspirin works in preventing colorectal cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.

Key facts

Study ID

NCT00468910

Run by

National Cancer Institute (NCI)

People needed

79

Starts

2007-03-01

Expected to finish

2011-08-01

Last updated by the study team

2017-05-31

Who can join

Age: any, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.